Checkpoint inhibitors and myeloma: promises, deadlocks and new directions

por Bertamini, Luca, Gay, Francesca
Publicado 2020

Autologous transplant for myeloma: when the old meets the new

por Gay, Francesca, Genuardi, Mariella, Boccadoro, Mario
Publicado 2017

Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma

por Bonello, Francesca, Mina, Roberto, Boccadoro, Mario, Gay, Francesca
Publicado 2019

Emerging drugs and combinations to treat multiple myeloma

por Larocca, Alessandra, Mina, Roberto, Gay, Francesca, Bringhen, Sara, Boccadoro, Mario
Publicado 2017

Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?

por Leleu, Xavier, Gay, Francesca, Flament, Anne, Allcott, Kim, Delforge, Michel
Publicado 2017

Moving Toward Continuous Therapy in Multiple Myeloma

por Bonello, Francesca, Cetani, Giusy, Bertamini, Luca, Gay, Francesca, Larocca, Alessandra
Publicado 2019

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma

por Oliva, Stefania, Troia, Rossella, D'Agostino, Mattia, Boccadoro, Mario, Gay, Francesca
Publicado 2018

Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies

por D’Agostino, Mattia, Bertamini, Luca, Oliva, Stefania, Boccadoro, Mario, Gay, Francesca
Publicado 2019

Editorial: Exploiting the Immune System to Treat Multiple Myeloma: From Transplantation to Novel Treatment Approaches

por van de Donk, Niels W. C. J., Kastritis, Efstathios, Gay, Francesca
Publicado 2020

Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?

por Bertuglia, Giuseppe, Cani, Lorenzo, Larocca, Alessandra, Gay, Francesca, D’Agostino, Mattia
Publicado 2022

Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR

por Weisel, Katja, Mateos, Maria-Victoria, Gay, Francesca, Delforge, Michel, Cook, Gordon, Szabo, Zsolt, Desgraz, Renaud, DeCosta, Lucy, Moreau, Philippe
Publicado 2020

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma

por Mateos, María-Victoria, Bladé, Joan, Bringhen, Sara, Ocio, Enrique M, Efebera, Yvonne, Pour, Luděk, Gay, Francesca, Sonneveld, Pieter, Gullbo, Joachim, Richardson, Paul G.
Publicado 2020

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy

por Bruno, Giulia, Bringhen, Sara, Maffei, Ilaria, Iannaccone, Andrea, Crea, Teresa, Ravera, Agnese, Astarita, Anna, Vallelonga, Fabrizio, Salvini, Marco, Gay, Francesca, Veglio, Franco, Milan, Alberto
Publicado 2019

Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-D...

por Astarita, Anna, Mingrone, Giulia, Airale, Lorenzo, Cesareo, Marco, Colomba, Anna, Catarinella, Cinzia, Leone, Dario, Gay, Francesca, Bringhen, Sara, Veglio, Franco, Milan, Alberto, Vallelonga, Fabrizio
Publicado 2023

Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience

por Mingrone, Giulia, Astarita, Anna, Colomba, Anna, Catarinella, Cinzia, Cesareo, Marco, Airale, Lorenzo, Paladino, Arianna, Leone, Dario, Vallelonga, Fabrizio, Bringhen, Sara, Gay, Francesca, Veglio, Franco, Milan, Alberto
Publicado 2023

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel

por Raje, Noopur, Anderson, Kenneth, Einsele, Hermann, Efebera, Yvonne, Gay, Francesca, Hammond, Sarah P., Lesokhin, Alexander M., Lonial, Sagar, Ludwig, Heinz, Moreau, Philippe, Patel, Krina, Ramasamy, Karthik, Mateos, Maria-Victoria
Publicado 2023

Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi Study

por Ramasamy, Karthik, Avet-Loiseau, Hervé, Hveding Blimark, Cecilie, Delforge, Michel, Gay, Francesca, Manier, Salomon, Martinez-Lopez, Joaquín, Mateos, Maria Victoria, Mohty, Mohamad, van de Donk, Niels W.C.J., Weisel, Katja
Publicado 2023

Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction

por Astarita, Anna, Mingrone, Giulia, Airale, Lorenzo, Vallelonga, Fabrizio, Covella, Michele, Catarinella, Cinzia, Cesareo, Marco, Bruno, Giulia, Leone, Dario, Giordana, Carlo, Cetani, Giusy, Salvini, Marco, Gay, Francesca, Bringhen, Sara, Rabbia, Franco, Veglio, Franco, Milan, Alberto
Publicado 2021

Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients

por Mingrone, Giulia, Astarita, Anna, Airale, Lorenzo, Maffei, Ilaria, Cesareo, Marco, Crea, Teresa, Bruno, Giulia, Leone, Dario, Avenatti, Eleonora, Catarinella, Cinzia, Salvini, Marco, Cetani, Giusy, Gay, Francesca, Bringhen, Sara, Veglio, Franco, Vallelonga, Fabrizio, Milan, Alberto
Publicado 2021

Cardiovascular adverse events in modern myeloma therapy – Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)...

por Bringhen, Sara, Milan, Alberto, Ferri, Claudio, Wäsch, Ralph, Gay, Francesca, Larocca, Alessandra, Salvini, Marco, Terpos, Evangelos, Goldschmidt, Hartmut, Cavo, Michele, Petrucci, Maria Teresa, Ludwig, Heinz, Auner, Holger W., Caers, Jo, Gramatzki, Martin, Boccadoro, Mario, Einsele, Hermann, Sonneveld, Pieter, Engelhardt, Monika
Publicado 2018